NASDAQ: ITOCItonic Holdings Ltd Stock
$0.43+0.03 (+7.5%)
Updated Jun 10, 2026
ITOC Price
$0.43
Fair Value Price
$0.43
Market Cap
$7.35M
52 Week Low
$0.25
52 Week High
$32.00
P/E
-1.36x
P/B
1.2x
P/S
12.91x
PEG
N/A
Dividend Yield
N/A
Revenue
$523.03k
Earnings
-$5.10M
Gross Margin
62.6%
Operating Margin
-974.68%
Profit Margin
-974.7%
Debt to Equity
0.16
Operating Cash Flow
-$3M
Beta
0.74
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ITOC Overview
iTonic Holdings Ltd., a healthcare solutions firm, specializes in the development and commercialization of software and devices for brachytherapy. Its advanced proprietary treatment planning system centers on radioactive particle implantation, a form of radiotherapy employed in cancer treatment to precisely position radioactive sources within patients, thereby eradicating malignant cells and reducing tumor size. Key among its offerings is FTTPS, a sophisticated treatment planning system engineered for diverse malignant tumors. This system excels at defining the target volume, determining the prescribed dose, establishing safety margins for organs at risk, and formulating a precise dose distribution plan essential for brachytherapy patients. Founded in Beijing, China, in 1998, the company operated as Pheton Holdings Ltd. until its rebranding to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. functions as a subsidiary of ZJW (BVI) LTD.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ITOC's potential to beat the market
- ITOC doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
C
ITOC
RankedUnranked of 94
RankedUnranked of 94
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $9.05 | A | |
| $37.18 | A | |
| $25.97 | A |
Be the first to know about important ITOC news, forecast changes, insider trades & much more!
ITOC News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ITOC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ITOC ($0.43) is overvalued by 1.32% relative to our estimate of its Fair Value price of $0.43 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ITOC ($0.43) is not significantly undervalued (1.32%) relative to our estimate of its Fair Value price of $0.43 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ITOC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ITOC due diligence checks available for Premium users.
Valuation
ITOC fair value
Fair Value of ITOC stock based on Discounted Cash Flow (DCF)
Price
$0.43
Fair Value
$0.43
Overvalued by
1.08%
ITOC ($0.43) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ITOC ($0.43) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ITOC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
ITOC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.36x
Industry
22.22x
Market
14.77x
ITOC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.2x
Industry
3.01x
ITOC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ITOC's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
ITOC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ITOC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$9.1M
Liabilities
$969.8k
Debt to equity
0.16
ITOC's short-term assets ($4.09M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ITOC's short-term assets ($4.09M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ITOC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
ITOC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ITOC vs Medical Device Stocks
Itonic Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.